Structured around providing accurate, affordable, and non-invasive methods for early cancer detection and health monitoring, Earlydiagnostics is a spinoff from UCLA and Stanford. Principals of the firm have developed a blood test - designated CancerLocator - that is accurate enough to detect cancer and is able also to pinpoint the tumor' s location. A second early stage devlopmenthas been a One-Stop Shop bioinformatics solution designed to facilitate many diagnostic companies being able to offer liquid biopsy tests on cancer detection, therapy selection, and treatment monitoring.
